TCTMD

Concept Medical received IDE approval to investigate safety and efficacy of its MagicTouch Sirolimus Coated Balloon Catheter for the treatment of small coronary artery disease

The US FDA has granted an Investigational Device Exemption (IDE) approval for Concept Medical Inc’s novel MagicTouch Sirolimus Coated Balloon (SCB) for the treatment of Small Vessels (SV) in coronary ...
TCTMD

Concept Medical’s fourth IDE approval for the MagicTouch Sirolimus Coated Balloon is granted for the treatment of Superficial Femoral Artery Disease (SFA)

The US FDA, on the 24th of May 2023, granted an Investigational Device Exemption (IDE) approval for Concept Medical Inc’s Sirolimus Coated Balloon (SCB) Magic Touch PTA for the treatment of ...
PR Newswire

CONCEPT MEDICAL RECEIVES US FDA IDE APPROVAL FOR MAGICTOUCH AVF INDICATION, THEIR FIFTH US CLINICAL STUDY APPROVAL FOR THE MAGICTOUCH PORTFOLIO

TAMPA, Fla., April 2, 2024 /PRNewswire/ -- Concept Medical has been granted 'IDE Approval' from the U.S. Food and Drug Administration (FDA) for MagicTouch AVF, its Sirolimus drug-coated balloon (DCB) ...
WTNH

Concept Medical Announces First Patient Enrollment in the MAGICAL BTK IDE Trial, Launching its PAD Clinical Program in the United States

TAMPA, Fla., Jan. 16, 2025 /PRNewswire/ -- Concept Medical Inc., a global pioneer in innovative drug delivery technology, is proud to announce the successful enrolment of the first patient in the ...
Hosted on MSN

Concept Medical Announces First Patient Enrollment In MAGICAL-SV IDE Trial, Expanding Its Coronary Clinical Program Across The US And Europe

Ahmedabad: Concept Medical Inc., a global pioneer in drug-delivery technologies having its manufacturing facilities in Surat on Monday announced the enrollment of the first patient in the MAGICAL-SV ...
Business Insider

Concept Medical Inc. Raises $60mn for Investigational Device Exemption (IDE) for the World's First Sirolimus-Coated Balloon

SURAT, India, Oct. 9, 2018 /PRNewswire/ -- Concept Medical Inc. Raises $60mn For Investigational Device Exemption (IDE) For The World's First Sirolimus-Coated Balloon. Concept Medical Inc. (CMI) has ...
Benzinga.com

Concept Medical's fourth IDE approval for the MagicTouch Sirolimus Coated Balloon is granted for the treatment of Superficial Femoral Artery Disease (SFA)

TAMPA, Fla., May 29, 2023 /CNW/ -- The US FDA, on the 24 th of May 2023, granted an Investigational Device Exemption (IDE) approval for Concept Medical Inc's Sirolimus Coated Balloon (SCB) MagicTouch ...